These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13807568)

  • 21. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
    Everlien H; Hockertz S
    Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Amphotericin B in the treatment of American tegumental leishmaniasis].
    MIRANDA JL; dos LIMA NS; da CUNHA J
    Hospital (Rio J); 1961 Jun; 59():1065-87. PubMed ID: 13771161
    [No Abstract]   [Full Text] [Related]  

  • 23. Amphotericin B for visceral leishmaniasis resistant to pentavalent antimonial drugs in AIDS.
    Rodilla F; Magraner J; Aznar J; Orovitg F; Alcácer F; Colomina J; Ferriols F
    Ann Pharmacother; 1994 Nov; 28(11):1305. PubMed ID: 7849352
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of infantile visceral leishmaniasis with solusurmin according to material of the parasitological department of the Tashkent City Sanitary-Epidemiological Station].
    MIKHAILOV VG; STARTSEVA MA
    Med Parazitol (Mosk); 1961; 30():563-7. PubMed ID: 14473694
    [No Abstract]   [Full Text] [Related]  

  • 25. [Our experience in the treatment of kala-azar].
    de YTURRIAGA E; GONZALEZ BOTELLA S
    Acta Pediatr Esp; 1950 May; 8(89):569-76. PubMed ID: 15418997
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical results in the treatment of American leishmaniasis with oral and intravenous amphotericin.
    FURTADO TA
    Antibiot Annu; 1959-1960; 7():631-7. PubMed ID: 13825745
    [No Abstract]   [Full Text] [Related]  

  • 27. Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro.
    Berman JD; Chulay JD; Hendricks LD; Oster CN
    Am J Trop Med Hyg; 1982 May; 31(3 Pt 1):459-65. PubMed ID: 7081539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of sodium antimony gluconate in mass treatment of kala-azar by the rate of disappearance of Leishman-Donovan bodies.
    HO EA; TAO CY; SUNG SJ
    Chin Med J; 1952; 70(5-6):243-52. PubMed ID: 13127087
    [No Abstract]   [Full Text] [Related]  

  • 29. Antimony-based antileishmanial compounds prolong the cardiac action potential by an increase in cardiac calcium currents.
    Kuryshev YA; Wang L; Wible BA; Wan X; Ficker E
    Mol Pharmacol; 2006 Apr; 69(4):1216-25. PubMed ID: 16418337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of visceral leishmaniasis with n-methyl-glucamine antimoniate].
    BOIX BARRIOS J; SANCHO PASQUAU V
    Presse Med (1893); 1951 Nov; 59(71):1475-7. PubMed ID: 14891720
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of natural antimony resistance in Leishmania donovani isolates.
    Mittal MK; Rai S; Ashutosh ; Ravinder ; Gupta S; Sundar S; Goyal N
    Am J Trop Med Hyg; 2007 Apr; 76(4):681-8. PubMed ID: 17426170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of visceral leishmaniasis with solusurmin in children].
    KARAKHODZHAEV BKh
    Pediatriia; 1953; 4():60-1. PubMed ID: 13088230
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
    Mandal S; Maharjan M; Singh S; Chatterjee M; Madhubala R
    J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experimental study on the antifungal action of 2 antiserotonins].
    GEISER JD
    Dermatologica; 1962; 124():245-8. PubMed ID: 13897538
    [No Abstract]   [Full Text] [Related]  

  • 35. [LEISHMANIASIS AS ENCOUNTERED IN FRANCE. CLINICAL AND THERAPEUTIC ASPECTS].
    SCHNEIDER J
    Rev Prat; 1964 Mar; 14():1149-63. PubMed ID: 14146424
    [No Abstract]   [Full Text] [Related]  

  • 36. [Visceral leishmaniasis: a possible diagnosis in Belgium].
    Desmyttere S; Hachimi-Idrissi S; Otten J
    Tijdschr Kindergeneeskd; 1993 Oct; 61(5):182-5. PubMed ID: 8266313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani.
    Kothari H; Kumar P; Sundar S; Singh N
    Parasitol Int; 2007 Mar; 56(1):77-80. PubMed ID: 17169604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LEISHMANIASIS IN THE SUDAN REPUBLIC. XXI. INFECTION IN AMERICAN PERSONNEL.
    CAHILL KM
    Am J Trop Med Hyg; 1964 Nov; 13():794-9. PubMed ID: 14222431
    [No Abstract]   [Full Text] [Related]  

  • 39. Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria.
    Eddaikra N; Ait-Oudhia K; Kherrachi I; Oury B; Moulti-Mati F; Benikhlef R; Harrat Z; Sereno D
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006310. PubMed ID: 29561842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic visceral leishmaniasis during chemotherapy for metastatic osteosarcoma].
    Marguglio A; Hoyoux C; Dresse MF; Chantraine JM; Thiry A; Gillet P
    Arch Pediatr; 1998 Mar; 5(3):285-8. PubMed ID: 10327996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.